The influence and related mechanisms of low-dose aspirin on uric acid metabolism in elderly people

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000031372

Enrollment

Unknown

Registered

2020-03-29

Start date

2020-05-01

Completion date

Unknown

Last updated

2020-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerotic cardiovascular disease, hyperuricemia

Interventions

case series:Non-intervention

Eligibility

Sex/Gender

All

Age

60 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age is equal to or greater than 60 years old; 2. Patients who have not taken aspirin or have taken low-dose aspirin (50mg / D, 100mg / D) for more than one month.

Exclusion criteria

Exclusion criteria: 1. Participants who are taking medicine interfering uric acid metabolism like uric acid lowering drugs, diuretics, losartan, antituberculosis drugs, cytotoxic drugs; 2. With comorbidities like hepatic insufficiency (Child-Pugh C level), renal failure (eGFR < 15ml/min*1.73?), intestinal post-operation; 3. Patients who drink, eat a lot of seafood and animal viscera.

Design outcomes

Primary

Measure	Time frame
Blood uric acid;Uric acid excretion fraction;Blood xanthine oxidase activity;	—

Countries

China

Contacts

Public ContactFan Yan

The First Hospital of Beijing University

fanyan7405@163.com+86 15201529027

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026